We demonstrate that the pro‐tumourigenic role of TAM‐MG in GBM is mediated by mTOR, as reduced tumour growth and increased survival were observed upon genetic silencing of the pathway in these cells in GL261 allografts. The gene discussed is MTOR; the disease is neoplasm.